Approval · Notice of Compliance 4304 · 1996
ROCEPHIN: Notice of Compliance 4304
Issued January 26, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4304
- Date
- January 26, 1996
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for a reduced reconstitution volume for intramuscular administration
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROCEPHIN | Not yet assigned | — |
Medicinal ingredients
- CEFTRIAXONE SODIUM 0.5 G per VIAL
- CEFTRIAXONE SODIUM 1 G per VIAL
- CEFTRIAXONE SODIUM 2 G per VIAL